Wake Pharm US Announces Appointment of Jeffrey A. Niezgoda, M.D. to the Board of Medica...( ELK GROVE VILLAGE Ill. June 29 /- Wak...),Health

ELK GROVE VILLAGE, Ill., June 29 /PRNewswire/ -- Wake Pharm US announced today the appointment of Jeffrey A. Niezgoda, MD, FACHM, FACEP, FAPWCA as Director of the Company's Medical Advisory Board.

Dr. Jeffrey Niezgoda is a leading wound management physician and the Medical Director of the Centers for Comprehensive Wound Care and Hyperbaric Oxygen Therapy in Milwaukee, Wisconsin. He also serves as the President and Chief Operating Officer of Hyperbaric & Wound Care Associates, a medical specialty group serving Southeastern Wisconsin and Northern Illinois, and as the President of the American College of Hyperbaric Medicine.

Dr. Niezgoda stated, "I am very pleased to accept the position of Director of the Advisory Board and to have the opportunity to contribute to the company's clinical mission. My clinical experience with Wound Be Gone(R) has produced impressive results with improved wound healing trajectories. Wound Be Gone(R) is placing wound care into the hands of people who might otherwise suffer or whose wound problems might escalate to need for expensive invasive medical intervention."

Ludek Lolek, President & CEO of Wake Pharm US commented, "Dr. Niezgoda has been an invaluable resource to the Wound Be Gone(R) brand. His clinical insight and experience has been a tremendous asset to our development team. As Director of our Medical Advisory Board, Dr. Niezgoda will help us to accelerate the growth of our product line."

Wound-Be-Gone(R) is a novel hydrophilic gel that has been shown to demonstrate enhanced wo
'/>"/>